They were on AMEX until last April....I'm looking more for either Bausch & Lomb, Pfizer or Inspire to buy out INSV in the $1.50-$2.50 range. Unless that Piper Jaffrey initiative comes up with a scenario where INSV buys out another late stage drug or company with a rich potential drug pipeline then back to NASDAQ or AMEX they might go.